Related Experiment Videos
The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3
B D Cohen1, P A Kiener, J M Green
1Molecular Immunology Department, Bristol-Myers Squibb, Pharmaceutical Research Institute, Seattle Washington 98121, USA.
The Journal of Biological Chemistry
|November 29, 1996
Summary
Combinations of human epidermal growth factor receptor (HER) family members drive cell transformation and tumor growth. Specific HER pairs, like HER1 and HER2, show aggressive tumor formation, while signaling pathways vary depending on the receptor combination.
Area of Science:
- Cell Biology
- Molecular Oncology
- Signal Transduction
Background:
- The human epidermal growth factor receptor (HER) family plays critical roles in cell growth and cancer.
- Understanding the specific roles of individual HER members and their combinations is crucial for targeted therapies.
Purpose of the Study:
- To investigate the functional consequences of expressing individual and paired HER family members in a cellular context.
- To determine the role of specific HER combinations in cellular transformation and tumor formation in vivo.
- To elucidate the signaling pathways, including calcium flux and phospholipase Cgamma1 activation, associated with HER activation.
Main Methods:
- Generation of NIH3T3 cell lines expressing single or paired HER family members.
- Assay for cellular transformation using soft agar growth.
- Tumorigenicity assessment in animal models.
- Analysis of intracellular calcium levels and phospholipase Cgamma1 phosphorylation.
Main Results:
- Cellular transformation required co-expression of two different HER family members and specific ligands.
- Oncogenic neu (Tneu) conferred ligand-independent transformation only when co-expressed with HER1, HER3, or HER4.
- HER1 and HER2 co-expression resulted in the most aggressive tumor formation.
- HER1 activation was necessary for calcium flux and phospholipase Cgamma1 phosphorylation, independent of other HER members.
- Heregulin-induced transformation via HER3/HER4 did not involve phospholipase Cgamma1 or calcium mobilization.
Conclusions:
- HER family member dimerization is critical for ligand-dependent transformation and tumorigenesis.
- Specific HER pair combinations dictate tumor aggressiveness and signaling pathway activation.
- Distinct signaling mechanisms mediate transformation depending on the activated HER complex and ligand.